Fluoxetine selectively alters 5-hydroxytryptamine(1A) and γ- aminobutyric acid(B) receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 115-122

  Beck, Sheryl G ^a   Birnstiel, Susanne ^a   Choi, Kue C ^a   Pouliot, Wendy A ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; DIMETHYL SULFOXIDE; FLUOXETINE; NORFLUOXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

AFTERHYPERPOLARIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG SELECTIVITY; HIPPOCAMPUS; HYPERPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BACLOFEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HIPPOCAMPUS; MALE; MEMBRANE POTENTIALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0030960450     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. 1A Receptors, ed. by C. T. Dourish, S. Ahleniup and P. H. Hutson. pp. 185-198. Ellis Norwood, Chichester. England. 1987.
2. B receptors to the same channels in hippocampus Science (Wash. DC) 234: 1261-1265, 1986.
3. ANURADE, R. AND NICOLL, R. A.: Pharmacologically distinct, actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J. Physiol. 394: 99-124, 1987.
4. AXELSON, D. A., DORAISWAMY, P. M., McDONALD, W. M., BOYKO, O. B., TUPLER, L. A., PATTERSON, L. J., NEMEROFF, C. B., ELLINWOOD, E. H. AND KRISHNAN, K. R.: Hypercortieolemia and hippocampal changes in depression, Psych. Res. 47: 163-173, 1993.
5. BECK, S. G., BIRNSTIEL, S., POULIOT, W. A. AND CHOI, K. C.: Baclofen concentration-response curves differ between hippocampal subfields. NeuroReport 6: 310-312, 1995.
6. 1A- mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J. Pharmacol. Exp. Ther. 283: 350-359, 1992.
7. BECK, S. G. AND HALLORAN, P. H.: Imipramine alters β-adrenergic, but not aerotonergic, mediated responses in rat hippocampal pyramidal cells, Brain Res. 504: 72-81, 1989.
8. BECK, S. G., LIST, T. J. AND CHOI, K. C.: Long- and short-term administration of corticosterone alters CA1 hippocampal neuronal properties. Neuroendocrinology 80: 261-272, 1994.
9. BILKEY, D. K. AND SCHWARTZKROIN, P. A.; Variation in electrophysiology and morphology of hippocampal CA3 pyramidal cells. Brain Res, 514: 77-83, 1990.
10. BLIER, P., CHAPUT, Y. AND DE MONTIONY, C.: Long-term 5-HT reuptake blockade but not monoamine oxidase inhibition decreases the function of terminal 5-HT autoreceptors: An elcctrophysiological study in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 337: 246-254, 1988.
11. BLIER, P., DE MONTIONY, C. AND CHAPUT, Y.: Modifications of the serotonin system by antidepressant treatments: Implications for therapeutic response in major depression. J. Clin. Psychopharmacol. 7: 24S-35S, 1987.
12. BREMNER, J. D., RANDALL, P., SCOTT, T. M., BRONEN, R. A., SEIBYL, J. P., SOUTHWICK, S. M., DELANEY, R. C., MCCARTHY, G., CHARNEY, D. S. AND INNIS, R. B.: MRI-based measurement of hippocampal volume in patients with combatrelated posttraumatic stress disorder. Am. J. Psych. 152: 973-981, 1995.
13. BROWN, D. A., GAHWILER, B. H., GRIFFITH, W. H. AND HALUWELL, J. V.: Membrane currents in hippocampal neurons. In Progress in Brain Research. Vol. 83, ed. by J. Storrn-Mathisen, J. Zimmer and O. P. Ottersen, pp. 141-160, Elsevier Science Publishers B. V., New York, 1990.
14. BROWN, T. H., FRICKE, R. A. AND FERKEL, D. H.: Passive electrical constants in three classes of hippocampal neurons. J. Neurophysiol. 46: 812-827, 1981.
15. CHAPUT, Y., DE MONTIGNY, C. AND BLIER, P.: Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5: 219-229, 1991.
16. H binding sites in rat central nervous system: A quantitative autoradiographic study. Neuroscience 34: 341-357, 1990.
17. COWEN, P. J.: Serotonin receptor subtypes in depression; Evidence from studies in neuroendocrine regulation. Clin. Neuropharmacol. 16: s6-s18, 1993.
18. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238: 248-253, 1986.
19. GJERRIS, A., SORENSEN, A. S., RAFAELSEN, O. J., WERDBLIN, L., ALLING, C. AND LINNOILA, M.; 5-HT and 5-HIAA in cerebrospinal fluid in depression. J. Affective Disorders 12: 13-22, 1987.
20. 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62: 2262-2268, 1994.
21. 1A receptors in rat brain membranes. Eur. J. Pharmacol. 288:173-186, 1995.
22. HALLIWELL, J. V. AND ADAMS, P. R.: Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250: 71-92, 1982.
23. 2 receptors in rat brain: An autoradiographic study. Synapse 14:324-331, 1993.
24. 2 receptors in the rat brain. J. Psych. Neurosci. 19: 63-67, 1994.
25. B receptor binding in rat brain. Neuroscience 52: 73-81, 1993.
26. LEONARD, B. E.: The comparative pharmacology of new antidepressants J. Clin. Psych. 54: 3-15, 1993.
27. LESCH, K. P., HOUGH, C. J., AULAKH, C. S., WOLOZIN, B. J., TOLLIVER, T. J., HILL, J. L., AKIYOSHI, J., CHUANG, D. M. AND MURPHY, D. L.: Fluoxetine modulates G protein alpha s. alpha q and alpha 12 subunit mRNA expression in rat brain, Eur. J. Pharmacol. 227: 233-237, 1992.
28. LLOYD, K. G., THURET, F. AND PILC, A.: Upregulation of gamma aminobutyric acid (GABA) B binding sites in rat frontal cortex: A common action of repeated administration of different classes of antidepressants and electroshock, J. Pharmacol. Exp. Ther. 235: 191-199, 1985.
29. MAGGI, A., U'PRICHARD, D. C. AND ENNA, S. J.: Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur. J. Pharmacol, 81: 91-98, 1980.
30. MELTZER, H. Y. AND LOWY, M. T.: The serotonin hypothesis of depression. In Psychopharmacology: The Third Generation of Progress, ed. by H. Y. Meltzer, pp. 513-526, Raven, New York, 1987.
31. 1A agonists and antidepressants. J. Pharmacol, Exp. Ther. 260: 16-20, 1992.
32. 1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. J. Neurophysiol. 71: 2161-2167, 1994.
33. o α-subunits in rat forebrain. Synapse 23: 246-257, 1996.
34. PAZOS, A. AND PALACIOS, J. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346: 205-230, 1985.
35. PEROUTKA, S. J. AND SNYDER, S. H.: Long-term antidepressant treatment decreases spiroperidol labeled serotonin receptor binding. Science (Wash. DC) 210: 88-90, 1980.
36. ROBINSON, D. S.; Serotonin receptor subtypes and affective disorders. Clin. Neuropharmacol. 16: sl-s5, 1993.
37. SPRUSTON, N. AND JOHNSTON, D.: Perforated patch-clamp analysis of the passive membrane properties of three classes of hippocampal neurons. J. Neurophysiol, 67: 508-529, 1992.
38. STOKES, P. E.: Fluoxetine: A five year review. Clin. Ther. 15: 216-243, 1993.
39. 1A-sensitive adenylyl cyclase of rodent hippocampal neurons: Effects of antidepressant treatments and chronic stimulation with agonists. J. Pharmacol. Exp. Ther. 257: 433-438, 1991.
40. 1A receptors in rat brain following antidepressant drug treatment. Synapse 4: 347-352, 1989.
41. WONG, D. T., BYMASTER, F. P. AND ENGLEMAN, E. A.: Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci. 5: 411-441, 1995.